Epilepsy, Focal Seizures, Partial Seizures
1 clinical trials · Condition
◉ Watch Epilepsy, Focal Seizures, Partial Seizures
| Record | Firm | Date |
|---|---|---|
| Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy (NCT03283371) | Biogen | 2018-03-20 |
Track Epilepsy, Focal Seizures, Partial Seizures automatically
Every clearance here is in the API, with alerts when new ones post.